title: Intraspinal release of substance P and calcitonin gene-related peptide during opiate dependence and withdrawal.
abstract: The antibody microprobe technique was used to study the release of immunoreactive substance P and immunoreactive calcitonin gene-related peptide within the lower lumbar spinal cord of anaesthetized spinalized cats pretreated twice daily for 3.5 days with increasing doses of morphine hydrochloride (2-20 mg/kg, i.p.). Both peptides were released in the region of the substantia gelatinosa during noxious cutaneous thermal stimulation or high-intensity electrical stimulation of a hind limb nerve. Intravenous administration of naloxone increased the nociceptive excitation of lumbar dorsal horn neurons, but did not alter the evoked release of immunoreactive substance P or immunoreactive calcitonin gene-related peptide in the superficial gray matter dorsal to these neurons. In addition, the release of both peptides was not significantly different to that detected under similar experimental conditions in opioid-naive cats. The results suggest that alterations in neuropeptide release from the central terminals of nociceptive primary afferent neurons do not occur during states of opiate dependence and withdrawal, and thus do not contribute to the characteristic signs of these phenomena in dependent animals.
authors.affiliation: Division of Neuroscience, John Curtin School of Medical Research, Australian National University, Canberra, A.C.T.
authors.forename: C R
authors.initials: CR
authors.lastname: Morton
authors.forename: W D
authors.initials: WD
authors.lastname: Hutchison
authors.forename: I A
authors.initials: IA
authors.lastname: Hendry
mesh_terms: D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism*; D002415:Cats; D007158:Immunologic Techniques; D009020:Morphine / Q000009:adverse effects*; D009270:Naloxone / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects; D012016:Reference Values; D013116:Spinal Cord / Q000378:metabolism*; D013373:Substance P / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000378:metabolism*
chemical_list: D013373:Substance P; D009270:Naloxone; D009020:Morphine; D015740:Calcitonin Gene-Related Peptide